NCT03806881View on ClinicalTrials.gov

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant

Enrolling by invitationOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

October 1, 2024

Study Completion Date

December 1, 2028

Conditions
Arthroplasty, Replacement, ShoulderGlenoid CavityOsteoarthritis of the Shoulder
Interventions
DEVICE

reversed glenoid prothesis

All patients will undergo a primary or revision arthroplasty with Glenius according to the routine practice at the investigation site and will be followed at specified visiting moments, during which radiological and clinical data will be gathered.

Trial Locations (4)

3000

University Hospital Leuven - Traumatology, Leuven

Unknown

AZ St-Elisabeth, Herentals

University Hospital Leuven - Orthopedics, Leuven

Sint-Maartenskliniek, Nijmegen

Sponsors

Lead Sponsor

Materialise
All Listed Sponsors
lead

Materialise

INDUSTRY

NCT03806881 - Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant | Biotech Hunter | Biotech Hunter